Picture of Alembic Pharmaceuticals logo

APLLTD Alembic Pharmaceuticals Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Annual cashflow statement for Alembic Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line9,99813,6816,2013,5466,318
Depreciation
Non-Cash Items1,210-8231,3632,122142
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-8,290-58.7-4,908-1,183-1,155
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities4,49114,6345,5247,2408,032
Capital Expenditures-7,349-6,595-4,256-4,434-3,275
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items32.7-1,793537-41.868.6
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-7,316-8,388-3,720-4,476-3,206
Financing Cash Flow Items3,203-9,335-520-482-494
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1,549-5,974-2,174-2,620-4,379
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1,272262-370144447